ArticleBiomaterials research2025
Photothermally Responsive Hydrogel Releases Basic Fibroblast Growth Factor to Promote the Healing of Infected Wounds.
Article in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Research progress and applications of functional hydrogels in nasal wound healing.Journal of biological engineering · 2026Review
- Advanced Hydrogel Functionalization Strategies for Burn-Related Wound Treatment.Biomaterials research · 2026Review
- 3D-Printed Colloidal Crystal Hydrogel Crown Fused with Machine Learning-Integrated Resistance Strain Sensor for Pressure Sensing.Biomaterials research · 2026Article
- Advances in mild photothermal hydrogel-based therapies for bone and soft tissue injuries.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment of infected wounds is often complicated by bacterial infection and impaired scar healing. Antibiotics and growth factors are typically utilized to address these clinical challenges and expedite wound healing. However, the use of hydrogels containing these therapeutic agents is often restricted to complex cases and increases treatment costs considerably. In this study, we developed a quaternized-chitosan-based hybrid hydrogel dressing (SQFB) with intrinsic antibacterial properties to address these limitations. The hybrid hydrogel contained interpenetrating polymer networks of basic fibroblast growth factor and black phosphorus nanosheets, facilitating a photothermal response that triggers the release of basic fibroblast growth factor upon near-infrared irradiation. In vitro experiments demonstrated that SQFB exhibits superior antibacterial, hemostatic, enhanced cell proliferation, and angiogenesis functions. Importantly, the results showed that SQFB can promote the healing of infected wounds by accelerating all 4 stages of wound repair while preventing scarring formation. RNA sequencing analysis revealed that combined treatment with SQFB and near-infrared irradiation can effectively modulate genes primarily associated with epithelial regeneration pathways and metabolic processes. Collectively, our findings suggest that this hybrid hydrogel holds great promise for the effective management of infected wounds.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.